Illness	Number of cases
Essential primary hypertension (I10.01)	37
Syncope and collapse (R55)	35
Heart failure (I50.01)	31
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	28
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	19
Volume depletion (E86)	18
Acute upper respiratory infections of multiple and unspecified sites - Acute upper respiratory infection unspecified (J06.9)	17
Other noninfective gastroenteritis and colitis - Noninfective gastroenteritis and colitis unspecified (K52.9)	15
Acute bronchitis - Acute bronchitis unspecified (J20.9)	11
Erysipelas (A46)	10

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	204
(9-984.7)	84
(9-984.8)	64
Computed tomography (CT) of the head without contrast medium (3-200)	38
(8-98g.11)	34
(9-984.9)	34
(8-98g.10)	29
(9-984.6)	24
Dressings for large areas of skin or serious skin diseases (8-191.00)	12
Computed tomography of the abdomen with contrast medium (3-225)	11

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0

External quality assurance according to the DMP

Diabetes mellitus Typ 1

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
23	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
16	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
16	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility